Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease adenocarcinoma
Phenotype C0242379|lung cancer
Sentences 39
PubMedID- 21611070 Biopsy of the lesion revealed a low grade adenocarcinoma, consistent with a primary lung cancer.
PubMedID- 20217555 To identify and characterize novel lung adenocarcinoma genes associated with lung cancer progression, we created a bioinformatics-based approach that focuses on human cell-cycle-regulated genes that have evolved only in higher organisms but not in lower eukaryotic cells.
PubMedID- 20418894 Tissue obtained from the left supraclavicular lymph node biopsy revealed a poorly differentiated adenocarcinoma resulting from lung cancer.
PubMedID- 23584303 Early stage non-small-cell lung cancer: surgical implications of the new adenocarcinoma classification.
PubMedID- 22719810 In the present study, we report on a case of a remarkable effect of gefitinib re-treatment in a lung cancer patient with lepidic predominant adenocarcinoma who had experienced favorable results from initial treatment with gefitinib.
PubMedID- 21352550 The percent of lung cancer patients with adenocarcinoma was lower in current and former smokers than in never-smokers (64.3% versus 79.9%, p = 0.0004), while the percent with squamous cell carcinoma was higher in smokers than in never-smokers (15.5% versus 8.3%, p = 0.028).
PubMedID- 21557161 Chylothorax was more common on the right side, in lobectomy cases, in cases with adenocarcinoma, and in patients with advanced stage lung cancer, but the difference did not reach statistical significance.
PubMedID- 22729036 High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and egfr [corrected] mutation.
PubMedID- 24932312 The present study investigated whether plasma mtdna concentrations in lung cancer patients with adenocarcinoma were altered during treatment with erlotinib, an epidermal growth factor receptor-tyrosine kinase inhibitor (egfr-tki), and whether this change has the potential to be used as a predictor of treatment response.
PubMedID- 24325900 Unfortunately, frozen section of a subcarinal lymph node obtained at mediastinoscopy revealed metastatic poorly differentiated adenocarcinoma consistent with stage iiia lung cancer.
PubMedID- 22588153 Four genes (tenascin-c, [c-x-c motif] ligand 14, s100 calcium binding protein a9, and keratin 17) were found to be upregulated in elf of non-small-cell lung cancer patients with adenocarcinoma or squamous cell carcinoma.
PubMedID- 24137392 Egfr mutations, which are mostly limited to the first four exons, occur more often in lung cancer patients with adenocarcinoma histology, asian origin, female gender and a non-smoking background (13,15).
PubMedID- 22253823 Nsclc accounts for about 80% of all lung cancer cases, with adenocarcinoma predominating.
PubMedID- 23617234 In this report, we described a case of synchronous bilateral lung cancers with eml4-alk positive adenocarcinoma in the right lung and adenocarcinoma in situ in the left, which was eml4-alk negative.
PubMedID- 26400209 Therefore, cb6f1 mice develop lung cancer of the adenocarcinoma type similar to humans, but it occurs very late in old mice.
PubMedID- 26174366 Non-small cell lung cancer (nsclc), of which adenocarcinoma (adc) and non-adc (including squamous cell carcinoma (sqcc), large cell lung carcinoma (lcc), and bronchial gland carcinoma (bgc)) account for the majority of cases, represents almost 80 % of primary lc cases.
PubMedID- 21483485 In this study, we determined the cells originating an infectious lung cancer of sheep (ovine pulmonary adenocarcinoma, opa) that is similar to some forms of human pulmonary adenocarcinoma.
PubMedID- 24026853 Second primary non-small-cell lung cancer: implications of the new adenocarcinoma classification in the challenging decision of the best surgical strategy.
PubMedID- 24811831 Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma.
PubMedID- 26010604 Nsclc comprises 85% of all lung cancer cases, with adenocarcinoma (ac) representing the major histological subtype of nsclc [1].
PubMedID- 22969248 When compared with patients in the old age group, females, non-smokers, and those with a more advanced stage at diagnosis and histologic type of adenocarcinoma were predominant in patients with lung cancer in the young age group.
PubMedID- 25257766 Kras mutations are the most common mutations in non-small cell lung cancer (nsclc) with adenocarcinoma histology.
PubMedID- 24885564 Background: although many of the recently approved genomically targeted therapies have improved outcomes for patients in non-small-cell lung cancer (nsclc) with lung adenocarcinoma, little is known about the genomic alterations that drive lung squamous cell cancer (scc) and development of effective targeted therapies in lung scc is a promising area to be further investigated.
PubMedID- 24008636 These tumors were pathologically diagnosed as synchronous multiple primary lung cancers with adenocarcinoma and squamous cell carcinoma.
PubMedID- 23154565 First case of combined small-cell lung cancer with adenocarcinoma harboring eml4-alk fusion and an exon 19 egfr mutation in each histological component.
PubMedID- 22429580 We identified the dynamic changes of the immune system by investigating the levels of t lymphocyte subsets in peripheral blood of lung cancer patients with advanced stage adenocarcinoma undergoing first line chemotherapy.
PubMedID- 23255847 In conclusion, among patients with resected non-small cell lung cancer, the proportions of female, adenocarcinoma, stage ia, and lobectomy patients have increased, and the five-year survival rate has gradually improved during the last 20 yr in korea.
PubMedID- 23584302 Early stage non-small-cell lung cancer: surgical implications of the new adenocarcinoma classification.
PubMedID- 25786242 Repeating the same test using lung cancer signatures of the same type—10 adenocarcinoma signatures—did not lead to much improvement.
PubMedID- 21847065 Alk translocation in non-small cell lung cancer with adenocarcinoma and squamous cell carcinoma markers.
PubMedID- 25859693 Blood samples (plasma) in study 1 (fhcrc study) were taken from newly diagnosed lung cancer patients with nsclc adenocarcinoma (mostly late stage) and were frequency matched with for age, gender and for general smoking history (current and former smokers) (table 1a).
PubMedID- 25330145 Conclusion: several unique features among patients with resected synchronous multiple lung cancers, including the presence of exclusively adenocarcinoma histology, are of prognostic significance.
PubMedID- 22210923 There were statistically significantly more lung cancer-specific deaths in patients with adenocarcinoma than in patients with squamous cell carcinoma (p= 0.001).
PubMedID- 26022944 Comparisons of the clinicopathological features and survival outcomes between lung cancer patients with adenocarcinoma and squamous cell carcinoma.
PubMedID- 26161361 The loss of blood group antigen a expression has a negative prognostic impact in stage i non-small cell lung cancer, especially in patients with adenocarcinoma (265).
PubMedID- 23494387 lung cancer patients with adenocarcinoma histology may benefit most from treg-targeted therapy.
PubMedID- 23180523 lung cancer, including adenocarcinoma, was the most common type of malignancy, present in 44 (67%) patients.
PubMedID- 22566257 A case of resected synchronous multiple primary lung cancer comprising adenocarcinoma and carcinoid (cancer-in-cancer).
PubMedID- 21411176 Serum samples from 29 healthy volunteers and 33 lung cancer patients with adenocarcinoma (n=12), squamous cell carcinoma (n=11), or small cell carcinoma (n=10) ranging from stage i to stage iv disease and lung tissue samples from 7 lung cancer patients including the tumor tissue and its surrounding normal tissue were used.

Page: 1